1-4 of 4
Thomas Klingebiel, Prof.
Close
Sort by
Journal Articles

CMV-Specific Cytokine-Induced Killer Cells Comprise Concomitant Cytotoxicity Against Leukemia and Cytomegalovirus

Verena Pfirrmann, Sarah Oelsner, Eva Rettinger, MD, Sabine Huenecke, PhD, Jindrich Cinatl, Prof., Winfried Wels, Prof., Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 5814.
https://doi.org/10.1182/blood.V124.21.5814.5814
Published: 2014
Journal Articles

Repetitive Infusions of Cytokine-Induced Killer (CIK) Cells for Treatment of Impending Relapse in High-Risk Leukemia Patients after Allogeneic Stem Cell Transplantation

Eva Rettinger, MD, Sabine Huenecke, PhD, Verena Pfirrmann, Michael Merker, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Halvard Boenig, Prof., Gesine Bug, MD, Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 2438.
https://doi.org/10.1182/blood.V124.21.2438.2438
Published: 2014
Journal Articles

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Eva Rettinger, MD, Michael Merker, MD, Hermann Kreyenberg, PhD, Thomas Krenn, MD, Matthias Dürken, MD, Jörg Faber, MD PhD, Sabine Huenecke, PhD, Claudia Brehm, PhD, Melanie Bremm, PhD, Shahrzad Bakhtiar, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 3953.
https://doi.org/10.1182/blood.V124.21.3953.3953
Published: 2014
Journal Articles

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Christoph Königs, Dominik Dunsch, Richard Linde, Thomas Klingebiel, Prof, Dr, Wolfhart Kreuz, PD
Journal: Blood
Blood (2004) 104 (11): 3832.
https://doi.org/10.1182/blood.V104.11.3832.3832
Published: 2004